MedPath

University Of Louisville

University Of Louisville logo
🇺🇸United States
Ownership
Private
Established
1798-01-01
Employees
5K
Market Cap
-
Website
http://www.louisville.edu

Procrit Versus Placebo to Determine Efficacy in Pre-Operative Major Surgical Oncology Operations

Phase 2
Withdrawn
Conditions
Cancer
Interventions
Drug: Placebo
First Posted Date
2008-02-27
Last Posted Date
2021-08-06
Lead Sponsor
University of Louisville
Registration Number
NCT00624312
Locations
🇺🇸

University of Louisville, Louisville, Kentucky, United States

A Pilot Clinical Trial of Pyruvate, Creatine, and Niacinamide in Progressive Supranuclear Palsy.

Not Applicable
Completed
Conditions
Progressive Supranuclear Palsy
Interventions
Dietary Supplement: Placebo
Dietary Supplement: Pyruvate, creatine, niacinamide
First Posted Date
2008-01-31
Last Posted Date
2017-04-10
Lead Sponsor
University of Louisville
Target Recruit Count
20
Registration Number
NCT00605930
Locations
🇺🇸

Frazier Rehab, Louisville, Kentucky, United States

Controlled Trial on Effect of Montelukast Treatment in Children With Obstructive Sleep Apnea Syndrome

Phase 2
Withdrawn
Conditions
Sleep Apnea
Interventions
Drug: Placebo
First Posted Date
2008-01-23
Last Posted Date
2017-04-10
Lead Sponsor
University of Louisville
Registration Number
NCT00599534
Locations
🇺🇸

University of Louisville Pediatric Sleep Medicine Center, Louisville, Kentucky, United States

🇺🇸

University of Louisville Pediatrics Sleep Medicine Center, Louisville, Kentucky, United States

Intelligent Control Approach to Anemia Management

Not Applicable
Completed
Conditions
End-Stage Renal Disease
Interventions
Other: ESA Dose Adjustment per "Smart Anemia Manager" Algorithm
Other: ESA Dose Adjustment per standard Anemia Management Protocol
First Posted Date
2007-12-13
Last Posted Date
2017-12-13
Lead Sponsor
University of Louisville
Target Recruit Count
62
Registration Number
NCT00572533
Locations
🇺🇸

University of Louisville Kidney Disease Program, Louisville, Kentucky, United States

Nasal Budesonide in Children With Rhinitis and/or Mild Obstructive Sleep Apnea Syndrome

Phase 4
Completed
Conditions
Obstructive Sleep Apnea
Interventions
Drug: placebo
First Posted Date
2007-11-19
Last Posted Date
2017-07-11
Lead Sponsor
University of Louisville
Target Recruit Count
62
Registration Number
NCT00560586
Locations
🇺🇸

Kosair Children's Hospital Sleep Center, Louisville, Kentucky, United States

Brain, Gut and Kidney Blood Flow During Medical Closure of PDA

Withdrawn
Conditions
Patent Ductus Arteriosus
Interventions
Device: INVOS Cerebral/Somatic oximeter
First Posted Date
2007-11-06
Last Posted Date
2015-01-26
Lead Sponsor
University of Louisville
Registration Number
NCT00554307
Locations
🇺🇸

Kosair Children's Hospital, Lousiville, Kentucky, United States

Adjuvant, Combined Interleukin 2 (Proleukin) and DTIC (Dacarbazine) in High-risk Melanoma Patients

Phase 2
Active, not recruiting
Conditions
Metastatic Melanoma
Interventions
First Posted Date
2007-11-04
Last Posted Date
2021-10-29
Lead Sponsor
University of Louisville
Target Recruit Count
160
Registration Number
NCT00553618
Locations
🇺🇸

James Graham Brown Cancer Center, Louisville, Kentucky, United States

Evaluating a Behavioral Activities Treatment Program for Depressed Nursing Home Residents

Not Applicable
Completed
Conditions
Depression
Interventions
Behavioral: BE-ACTIV
Behavioral: Treatment as usual (TAU)
First Posted Date
2007-09-27
Last Posted Date
2017-04-13
Lead Sponsor
University of Louisville
Target Recruit Count
20
Registration Number
NCT00536406
Locations
🇺🇸

University of Louisville, Louisville, Kentucky, United States

Vaccine Therapy in Treating Patients Who Have Undergone a Donor Stem Cell Transplant and Have Cytomegalovirus Infection That Has Not Responded to Therapy

Phase 1
Completed
Conditions
Cancer
Interventions
Biological: cytomegalovirus pp65-specific cytotoxic T lymphocytes
Genetic: polymerase chain reaction
Other: diagnostic laboratory biomarker analysis
Other: flow cytometry
Other: immunologic technique
First Posted Date
2007-07-31
Last Posted Date
2017-05-09
Lead Sponsor
University of Louisville
Target Recruit Count
20
Registration Number
NCT00509691
Locations
🇺🇸

Penn State Hershey Cancer Institute at Milton S. Hershey Medical Center, Hershey, Pennsylvania, United States

Pharmacokinetics of Immediate-Release vs. Delayed-Release Omeprazole in Gastroparesis

Phase 4
Completed
Conditions
Gastroparesis
Gastroesophageal Reflux Disease
Interventions
First Posted Date
2007-06-27
Last Posted Date
2017-07-28
Lead Sponsor
University of Louisville
Target Recruit Count
12
Registration Number
NCT00492622
Locations
🇺🇸

Digestive Health Center, University of Louisville Hospital, Louisville, Kentucky, United States

© Copyright 2025. All Rights Reserved by MedPath